Affiliated Managers Group, Inc., through its affiliates, operates as an investment management company providing investment management services to mutual funds, institutional clients,retails and high net worth individuals in the United States. It provides advisory or sub-advisory services to mutual funds. These funds are distributed to retail, high net worth and institutional clients directly and through intermediaries, including independent investment advisors, retirement plan sponsors, broker-dealers, major fund marketplaces, and bank trust departments. The company also offers investment products in various investment styles in the institutional distribution channel, including small, small/mid, mid, and large capitalization value and growth equity, and emerging markets. In addition, it offers quantitative, alternative, and fixed income products, and manages assets for foundations and endowments, defined benefit, and defined contribution plans for corporations and municipalities. Affiliated Managers Group provides investment management or customized investment counseling and fiduciary services. Affiliated Managers Group, Inc. was formed in 1993 and is based in West Palm Beach, Florida with additional offices in Prides Crossing, Massachusetts; Stamford, Connecticut; London, United Kingdom; Dubai, United Arab Emirates; Sydney, Australia; Hong Kong; Tokyo, Japan, Zurich, Switzerland and Delaware.

Affiliated Managers Group Inc.

SilverCrest Asset Management ( ($SAMG) ) has issued an announcement. On June 18, 2026, Silvercrest L.P. and certain borrower subsidiaries entered i...

SilverCrest Asset Management Amends and Extends Credit Facilities

An announcement from Amigo Holdings PLC ( ($GB:AMGO) ) is now available. Amigo Resources PLC has completed a strategic overhaul, exiting its legacy...

Amigo Resources pivots to African mining with fresh capital and new strategy

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen is running a phase 3 trial to compare its eye drug ABP 938 8 mg with E...

Amgen’s ABP 938 Takes Aim at EYLEA HD in High-Stakes Eye Disease Trial

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 MARITIME-SWITCH trial looks at adults with obesity or ov...

Amgen’s MARITIME-SWITCH Trial Targets GLP-1 Switchers in the Growing Obesity Drug Market

Amigo Holdings PLC ( ($GB:AMGO) ) has provided an update. Amigo Resources PLC has reported highly encouraging geochemical results from its Kabete P...

Amigo Resources Flags Tier-1 Gold Targets and Processing Push at Kabete

Affiliated Managers ( ($AMG) ) has shared an announcement. On June 9, 2026, Affiliated Managers Group, Inc. entered into a Fourth Amended and Resta...

Affiliated Managers Establishes New $1.25 Billion Credit Facility

This week, several dividend stocks are trading close to their 52-week lows. Here is a list of ten such stocks that are also reaching their ex-divid...

10 Dividend Stocks to Check Out This Week

An announcement from MetalNRG Plc ( ($GB:AMG) ) is now available. Atlas Metals Group reported that shareholders approved all resolutions at its 3 J...

Atlas Metals Wins Strong Shareholder Backing for Governance and Capital Flexibility at AGM

Affiliated Managers ( ($AMG) ) just unveiled an update. At its Annual Meeting of Stockholders held on May 27, 2026, Affiliated Managers Group, Inc....

Affiliated Managers Shareholders Reaffirm Board and Governance Structure

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has launched a phase 1b study in small cell lung cancer that test...

Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study

Amgen ( ($AMGN) ) has provided an update. At its annual meeting held on May 19, 2026, Amgen stockholders re-elected all 12 director nominees to one...

Amgen Shareholders Reaffirm Board, Pay and Auditors

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen is running a new early-stage trial called “A Phase 1b, Open-label Stud...

Current Quarter	$7.58	Next Quarter	$7.78
Current Year	$34.71	Next Year	$38.72
QoQ Growth	+2.6%	YoY Growth	+11.6%
3Y EPS CAGR	-5.4%	Target Price	$379.86
Consensus	Buy	Upside	+7.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AMG	$352.90	-0.78%	646.67K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AMG	$352.90	-0.8%	646.67K
3
4
5
6

AMG

AMG

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Affiliated Managers Group Inc. Data in Excel

Get Affiliated Managers Group Inc. Data in Excel